Behandling af patienter med nyresygdom i slutstadiet skal udføres med forsigtighed, da der er begrænset klinisk erfaring og akkumulation af en metabolit (med ukendt farmakologisk aktivitet).
Treatment of patients with end-stage renal disease should be made with caution as there is little clinical experience and accumulation of a metabolite (with no known pharmacological activity).